Clinical Trial

NIBS Therapy in Subacute Spinal Cord Injury

Study acronym: NIBS-SCI1
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated April 30, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
No accepted clinical therapies exist for repair of motor pathways following spinal cord injury (SCI) in humans, leaving permanent disability and devastating personal and socioeconomic cost. A robust neural repair strategy has been demonstrated in preclinical studies, that is ready for translation to recovery of hand and arm function in human SCI, comprising daily transcranial magnetic stimulation treatment at the inpatient rehabilitation facility. This study will establish clinical effect size of the intervention, as well as safety and feasibility necessary for a subsequent controlled efficacy trial and inform preclinical studies for dosing optimization.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-31; most recent amendment 2025-04-28.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-04-28
Trial Details
NCT Number NCT06247904
Lead Sponsor Albert Einstein Healthcare Network
Collaborators: Pennsylvania Department of Health, University of Mississippi Medical Center, University of Sao Paulo, Massachusetts General Hospital, Weill Medical College of Cornell University, Burke Medical Research Institute
Conditions Traumatic Spinal Cord Injury, Tetraplegia/Tetraparesis
Enrollment 20 participants
Start Date 2025-04-09
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-30